Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
    Users Online: 871
Home Print this page Email this page Small font size Default font size Increase font size
REVIEW ARTICLE
Year : 2021  |  Volume : 10  |  Issue : 2  |  Page : 73-79

Impact of clinical pharmacist-led medication reconciliation on therapeutic process


1 Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, University of Gezira, Gezira, Sudan
2 Department of Gastroenterology, Medicine, Faculty of Medicine, University of Gezira, Gezira, Sudan

Correspondence Address:
Mirghani Abd Elrahman Yousif
Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, University of Gezira, Gezira
Sudan
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/sjhs.sjhs_6_21

Rights and Permissions

The role of clinical pharmacists in the medication reconciliation (MR) process has been limited in the literature. Medication discrepancies and drug-related problems are safety challenges for hospitalized patients and healthcare professionals. The MR process is a standard practical tool at different hospital settings to optimize the correct use of medicines. The aim of this review was to evaluate the role of clinical pharmacists in the implementation of MR process at different practice settings. A literature search of Google Scholar, PubMed, ScienceDirect, and ELSEVIER for “medication reconciliation” and “medication discrepancies” with “clinical pharmacist” from 2011 up to September 2020 was conducted. The search findings revealed that; clinical pharmacist is the most capable health care provider in implementation of MR process due to his vast experience in medication history taking and drug therapy management. Medication discrepancies that can result in serious discomfort or clinical impairment of patients can be prevented by a clinical pharmacist-led MR process. Studies confirmed that clinical pharmacist's interventions contribute substantially to the detection and resolution of medication discrepancies in hospitalized patients. Moreover, another estimated benefit of pharmacist-led MR was cost reduction for patients, families, and healthcare system. These findings highly recommend further inclusion of a clinical pharmacist in a team-based MR in different health settings.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1470    
    Printed42    
    Emailed0    
    PDF Downloaded200    
    Comments [Add]    

Recommend this journal